| Motif ID |
Motif Logo |
Scanned Score Distribution |
Frequency of Motif |
Replicability Score |
Evolutionary Conservation Score |
Gene Targets |
Gene Ontology of CpGMM targets |
| CG_ff_promoter_p_PM_14_27_9 |
 |
 |
3 |
1.0 |
8.20E-05 |
TCF7L1,
GDPGP1 |
GDP-D-glucose phosphorylase activity [MF],
positive regulation of transcription from RNA polymerase II promoter during mitosis [BP] |
| CG_ff_promoter_p_PM_12_7_12 |
 |
 |
1 |
0.5 |
2.24E-04 |
TCTN1 |
central nervous system interneuron axonogenesis [BP] |
| CG_ff_promoter_p_PM_20_6_36 |
 |
 |
2 |
1.0 |
4.33E-05 |
WDR5,
SETD1B,
RAC1,
CUL5 |
histone methyltransferase activity (H3-K4 specific) [MF],
regulation of respiratory burst [BP],
response to osmotic stress [BP],
Set1C/COMPASS complex [CC] |
| CG_ff_promoter_p_PM_12_103_9 |
 |
 |
2 |
0.5 |
2.68E-05 |
KDM1A |
regulation of primitive erythrocyte differentiation [BP] |
| CG_ff_promoter_p_PM_20_10_37 |
 |
 |
2 |
1.0 |
5.00E-05 |
DDX3X,
DDX42,
PLEKHH2,
DDX55,
EIF4EBP1,
DMRTC2,
EP400,
DDX27,
ERAL1,
EIF2B5 |
translation initiation factor binding [MF],
negative regulation of actin filament depolymerization [BP],
ribosomal small subunit binding [MF],
negative regulation of protein complex assembly [BP],
eukaryotic initiation factor 4E binding [MF],
sex differentiation [BP],
helicase activity [MF],
ATP-dependent helicase activity [MF] |
| CG_ff_promoter_p_PM_12_105_4 |
 |
 |
1 |
0.5 |
3.39E-05 |
CCL2 |
response to vitamin B3 [BP],
helper T cell extravasation [BP],
negative regulation of natural killer cell chemotaxis [BP] |
| CG_ff_promoter_p_PM_12_170_6 |
 |
 |
2 |
1.0 |
2.89E-04 |
CSF3 |
granulocyte colony-stimulating factor receptor binding [MF] |
| CG_ff_promoter_p_PM_12_55_5 |
 |
 |
1 |
0.5 |
2.93E-05 |
ROR1,
SLC29A1,
APCDD1 |
Wnt-protein binding [MF],
uridine transport [BP] |
| CG_ff_promoter_p_PM_18_2_14 |
 |
 |
1 |
0.5 |
1.86E-05 |
MRI1 |
S-methyl-5-thioribose-1-phosphate isomerase activity [MF],
L-methionine biosynthetic process from S-adenosylmethionine [BP] |
| CG_ff_promoter_p_PM_14_73_8 |
 |
 |
2 |
1.0 |
5.53E-05 |
ANG |
angiogenin-PRI complex [CC] |
| CG_ff_promoter_p_PM_14_21_5 |
 |
 |
1 |
0.5 |
7.81E-05 |
GNA11 |
regulation of action potential [BP] |
| CG_ff_promoter_p_PM_12_176_4 |
 |
 |
1 |
0.5 |
2.90E-04 |
LDHC |
lactate oxidation [BP] |
| CG_ff_promoter_p_PM_12_62_6 |
 |
 |
1 |
0.5 |
1.03E-04 |
CASP8,
GRHPR |
Noc1p-Noc2p complex [CC],
glycerate dehydrogenase activity [MF],
hydroxypyruvate reductase activity [MF],
glyoxylate reductase (NADP) activity [MF] |
| CG_ff_promoter_p_PM_18_36_64 |
 |
 |
3 |
1.0 |
5.32E-05 |
HTRA2,
AZU1,
CFD |
serine-type endopeptidase activity [MF],
serine-type peptidase activity [MF] |
| CG_ff_promoter_p_PM_12_146_6 |
 |
 |
2 |
1.0 |
4.87E-05 |
RIPK2 |
response to interleukin-18 [BP] |
| CG_ff_promoter_p_PM_18_18_10 |
 |
 |
1 |
0.5 |
9.01E-05 |
GALM |
aldose 1-epimerase activity [MF] |
| CG_ff_promoter_p_PM_12_91_12 |
 |
 |
1 |
0.5 |
2.45E-04 |
B3GNT5,
RARA |
beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [MF],
lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity [MF],
glycolipid biosynthetic process [BP],
Sertoli cell fate commitment [BP],
lipopolysaccharide N-acetylglucosaminyltransferase activity [MF] |
| CG_ff_promoter_p_PM_12_113_5 |
 |
 |
1 |
0.5 |
1.57E-04 |
ADRBK1 |
negative regulation of the force of heart contraction by chemical signal [BP] |
| CG_ff_promoter_p_PM_20_14_38 |
 |
 |
2 |
1.0 |
6.61E-05 |
UBE2B,
RPL26L1,
ST6GAL1,
SMARCA4,
EIF2B5,
MARCH5,
ACTL6A,
TOMM22,
GCNT1,
CCT6A,
TIMM22,
RNF146,
RPS11 |
protein autoubiquitination [BP],
protein localization to mitochondrion [BP],
npBAF complex [CC],
protein transmembrane transporter activity [MF],
cellular protein metabolic process [BP] |
| CG_ff_promoter_p_PM_18_30_25 |
 |
 |
2 |
1.0 |
2.31E-05 |
DBI |
benzodiazepine receptor binding [MF] |
| CG_ff_promoter_p_PM_12_22_10 |
 |
 |
2 |
1.0 |
1.87E-04 |
PIN1,
AMH |
phosphothreonine binding [MF],
gonadal mesoderm development [BP],
preantral ovarian follicle growth [BP] |
| CG_ff_promoter_p_PM_12_153_5 |
 |
 |
2 |
1.0 |
4.59E-05 |
ACVR2B,
ZNF326,
NDUFAF5 |
activin receptor activity, type II [MF],
extrinsic to mitochondrial inner membrane [CC],
DBIRD complex [CC] |
| CG_ff_promoter_p_PM_16_6_14 |
 |
 |
2 |
1.0 |
2.99E-05 |
SIPA1L1 |
regulation of dendritic spine morphogenesis [BP],
activation of Rap GTPase activity [BP] |
| CG_ff_promoter_p_PM_18_1_18 |
 |
 |
1 |
0.5 |
4.72E-05 |
PIK3CD,
PIK3R2,
GMPR2,
MSX1,
SNAI1,
DGUOK |
cartilage morphogenesis [BP],
purine-containing compound salvage [BP],
phosphatidylinositol 3-kinase complex [CC],
phosphatidylinositol-3-phosphate biosynthetic process [BP],
phosphatidylinositol 3-kinase activity [MF],
1-phosphatidylinositol-3-kinase activity [MF] |
| CG_ff_promoter_p_PM_12_57_6 |
 |
 |
2 |
1.0 |
8.16E-05 |
SKIV2L,
DDX18,
PAX7 |
satellite cell commitment [BP],
ATP-dependent RNA helicase activity [MF] |
| CG_ff_promoter_p_PM_18_11_32 |
 |
 |
1 |
0.5 |
3.77E-05 |
SNX7,
NCF4,
ATRAID,
PPP4R2,
RGS6,
FBXO6,
DCPS,
ZNF143,
RAB8A,
CDC16,
MAML1,
PARD6B,
PLEKHH1,
RAB22A,
PVRL2,
SRPX2,
NFKB2,
AGTRAP,
ADRM1,
MED12,
ORAI1,
FNTA,
RAC1,
CDC42EP1,
KPNB1,
CD40,
EP300,
DNAJA1,
ZNRF1,
NME2,
CIRH1A,
SLC3A2,
AKAP9,
RAI14,
SPIRE2,
ADNP2,
ATP6V0A1,
LDLRAP1,
CNST |
protein binding [MF],
cytoskeleton [CC],
cell cortex [CC],
phagocytic vesicle [CC],
cytoplasmic vesicle membrane [CC],
androgen receptor signaling pathway [BP],
intracellular steroid hormone receptor signaling pathway [BP] |
| CG_ff_promoter_p_PM_20_18_59 |
 |
 |
2 |
1.0 |
8.05E-05 |
MAU2,
CASP8,
RB1,
NCR1 |
positive regulation of macrophage differentiation [BP],
maintenance of mitotic sister chromatid cohesion [BP],
SWI/SNF complex [CC] |
| CG_ff_promoter_p_PM_12_131_6 |
 |
 |
2 |
1.0 |
2.21E-04 |
MYD88,
IKBKG,
GAA,
BRCA2 |
diaphragm contraction [BP],
sucrose metabolic process [BP],
maltose metabolic process [BP],
toll-like receptor 1 signaling pathway [BP],
BRCA2-MAGE-D1 complex [CC],
vacuolar sequestering [BP] |
| CG_ff_promoter_p_PM_12_99_8 |
 |
 |
1 |
0.5 |
1.13E-04 |
TGM4 |
protein polyamination [BP] |
| CG_ff_promoter_p_PM_12_70_6 |
 |
 |
1 |
0.5 |
6.66E-05 |
BAG4 |
negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [BP] |
| CG_ff_promoter_p_PM_12_64_6 |
 |
 |
1 |
0.5 |
2.86E-05 |
HHEX |
gall bladder development [BP],
hepatoblast differentiation [BP],
negative regulation of vascular endothelial growth factor receptor signaling pathway [BP],
hepatic duct development [BP],
negative regulation of transcription by transcription factor localization [BP],
common bile duct development [BP],
protein localization to nucleus [BP] |
| CG_ff_promoter_p_PM_14_31_9 |
 |
 |
3 |
1.0 |
1.14E-04 |
F2,
DCLRE1B,
FKBP4 |
positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway [BP],
telomeric 3' overhang formation [BP],
steroid hormone receptor complex assembly [BP] |
| CG_ff_promoter_p_PM_18_26_42 |
 |
 |
1 |
0.5 |
6.08E-05 |
SIRT1 |
regulation of smooth muscle cell apoptotic process [BP] |
| CG_ff_promoter_p_PM_16_30_58 |
 |
 |
1 |
0.5 |
6.92E-05 |
ASL |
arginine biosynthetic process via ornithine [BP],
argininosuccinate lyase activity [MF] |
| CG_ff_promoter_p_PM_12_139_8 |
 |
 |
1 |
0.5 |
1.71E-04 |
SWSAP1,
PNPLA3 |
mono-olein transacylation activity [MF],
Shu complex [CC],
diolein transacylation activity [MF] |
| CG_ff_promoter_p_PM_12_133_7 |
 |
 |
2 |
1.0 |
3.34E-05 |
ACE,
LEP |
regulation of vasoconstriction [BP],
cellular response to L-ascorbic acid [BP],
negative regulation of glutamine transport [BP] |
| CG_ff_promoter_p_PM_14_69_5 |
 |
 |
2 |
1.0 |
5.45E-06 |
PRKCG |
positive regulation of mismatch repair [BP] |
| CG_ff_promoter_p_PM_12_78_4 |
 |
 |
1 |
0.5 |
3.14E-05 |
MARCKS |
germinal vesicle [CC] |
| CG_ff_promoter_p_PM_12_85_5 |
 |
 |
2 |
1.0 |
7.95E-05 |
XYLB,
CCNY,
PPIA,
SLC22A5 |
sodium-dependent organic cation transport [BP],
xylulokinase activity [MF],
uncoating of virus [BP],
cytoplasmic cyclin-dependent protein kinase holoenzyme complex [CC],
positive regulation of intestinal epithelial structure maintenance [BP],
quorum sensing involved in interaction with host [BP],
xylulose catabolic process [BP] |
| CG_ff_promoter_p_PM_16_29_18 |
 |
 |
2 |
1.0 |
8.80E-05 |
PHAX |
snRNA export from nucleus [BP] |
| CG_ff_promoter_p_PM_12_107_4 |
 |
 |
1 |
0.5 |
3.87E-05 |
SAMM50,
TALDO1 |
sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [MF],
mitochondrial sorting and assembly machinery complex [CC] |
| CG_ff_promoter_p_PM_14_25_10 |
 |
 |
2 |
1.0 |
4.84E-05 |
B4GALT7,
CTNND1,
HELT |
xylosylprotein 4-beta-galactosyltransferase activity [MF],
GABAergic neuron differentiation in basal ganglia [BP],
epithelial cell differentiation involved in salivary gland development [BP] |
| CG_ff_promoter_p_PM_16_4_60 |
 |
 |
2 |
1.0 |
5.93E-05 |
STX3,
CAMP,
HIPK3,
MAPK8,
CDC42,
TRAF3 |
specific granule [CC],
peptidyl-threonine phosphorylation [BP],
thioesterase binding [MF] |
| CG_ff_promoter_p_PM_12_166_9 |
 |
 |
1 |
0.5 |
6.31E-05 |
TARS2 |
mitochondrial threonyl-tRNA aminoacylation [BP] |
| CG_ff_promoter_p_PM_12_60_2 |
 |
 |
1 |
0.5 |
2.25E-04 |
FN3K |
fructosamine-3-kinase activity [MF],
fructoselysine metabolic process [BP] |
| CG_ff_promoter_p_PM_14_63_6 |
 |
 |
2 |
1.0 |
7.56E-05 |
C5AR1 |
complement receptor mediated signaling pathway [BP],
C5a anaphylatoxin receptor activity [MF],
complement component C5a binding [MF] |
| CG_ff_promoter_p_PM_12_51_7 |
 |
 |
2 |
1.0 |
1.59E-04 |
TGS1 |
RNA trimethylguanosine synthase activity [MF],
7-methylguanosine cap hypermethylation [BP] |
| CG_ff_promoter_p_PM_12_137_6 |
 |
 |
1 |
0.5 |
5.78E-05 |
PBX3 |
anterior compartment pattern formation [BP],
posterior compartment specification [BP] |
| CG_ff_promoter_p_PM_16_41_16 |
 |
 |
2 |
1.0 |
2.16E-05 |
TRAF4,
WBP1 |
WW domain binding [MF] |
| CG_ff_promoter_p_PM_12_76_7 |
 |
 |
1 |
0.5 |
2.48E-05 |
APOC3 |
negative regulation of cholesterol import [BP],
negative regulation of high-density lipoprotein particle clearance [BP] |
| CG_ff_promoter_p_PM_18_9_20 |
 |
 |
1 |
0.5 |
2.20E-05 |
POLR3G,
NFKBIB |
gene expression [BP],
positive regulation of type I interferon production [BP] |
| CG_ff_promoter_p_PM_12_101_6 |
 |
 |
2 |
0.5 |
7.32E-05 |
PIGG,
PDXK |
lithium ion binding [MF],
pyridoxal phosphate biosynthetic process [BP],
pyridoxal 5'-phosphate salvage [BP],
CP2 mannose-ethanolamine phosphotransferase activity [MF],
pyridoxal kinase activity [MF] |
| CG_ff_promoter_p_PM_14_53_21 |
 |
 |
1 |
0.5 |
2.28E-05 |
D2HGDH,
PLOD1 |
hydroxylysine biosynthetic process [BP],
(R)-2-hydroxyglutarate dehydrogenase activity [MF] |
| CG_ff_promoter_p_PM_14_16_6 |
 |
 |
1 |
0.5 |
3.95E-05 |
HMGA1 |
oncogene-induced senescence [BP],
senescence-associated heterochromatin focus [CC] |
| CG_ff_promoter_p_PM_14_55_7 |
 |
 |
2 |
1.0 |
5.37E-05 |
ZFPM1 |
regulation of definitive erythrocyte differentiation [BP],
primitive erythrocyte differentiation [BP],
transcriptional activation by promoter-enhancer looping [BP],
negative regulation of mast cell differentiation [BP],
mitral valve formation [BP],
negative regulation of interleukin-4 biosynthetic process [BP],
tricuspid valve formation [BP] |
| CG_ff_promoter_p_PM_12_19_4 |
 |
 |
1 |
0.5 |
2.46E-04 |
TERF2IP |
negative regulation of DNA recombination at telomere [BP] |
| CG_ff_promoter_p_PM_16_38_31 |
 |
 |
2 |
1.0 |
7.09E-05 |
WNT1 |
midbrain-hindbrain boundary maturation during brain development [BP],
negative regulation of DNA damage checkpoint [BP],
cerebellum formation [BP] |
| CG_ff_promoter_p_PM_12_31_7 |
 |
 |
1 |
0.5 |
5.76E-05 |
EXO1,
DLAT |
double-stranded DNA specific 5'-3' exodeoxyribonuclease activity [MF],
mitochondrial pyruvate dehydrogenase complex [CC],
dihydrolipoyllysine-residue acetyltransferase activity [MF],
single-stranded DNA specific 5'-3' exodeoxyribonuclease activity [MF] |
| CG_ff_promoter_p_PM_18_32_20 |
 |
 |
2 |
1.0 |
5.64E-05 |
DLX1 |
regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment [BP],
cerebral cortex GABAergic interneuron fate commitment [BP] |
| CG_ff_promoter_p_PM_14_46_13 |
 |
 |
2 |
1.0 |
8.16E-05 |
D2HGDH |
(R)-2-hydroxyglutarate dehydrogenase activity [MF] |
| CG_ff_promoter_p_PM_18_4_14 |
 |
 |
1 |
0.5 |
2.32E-05 |
AGPAT6,
PLD2,
LTC4S,
GLI2 |
glandular epithelial cell maturation [BP],
phosphatidic acid biosynthetic process [BP],
spinal cord ventral commissure morphogenesis [BP],
smoothened signaling pathway involved in ventral spinal cord interneuron specification [BP],
notochord regression [BP],
smoothened signaling pathway involved in spinal cord motor neuron cell fate specification [BP],
leukotriene-C4 synthase activity [MF] |
| CG_ff_promoter_p_PM_12_44_9 |
 |
 |
1 |
0.5 |
6.24E-05 |
ATP2A1,
DAK,
GDF7 |
roof plate formation [BP],
glycerone kinase activity [MF],
relaxation of skeletal muscle [BP],
elevation of endoplasmic reticulum calcium ion concentration [BP],
maintenance of mitochondrion location [BP],
triokinase activity [MF],
positive regulation of tendon cell differentiation [BP],
positive regulation of fast-twitch skeletal muscle fiber contraction [BP],
FAD-AMP lyase (cyclizing) activity [MF],
H zone [CC] |
| CG_ff_promoter_p_PM_16_31_10 |
 |
 |
2 |
1.0 |
3.82E-05 |
RPL27A,
EEF1B2,
RPL13A |
translational elongation [BP] |
| CG_ff_promoter_p_PM_16_35_38 |
 |
 |
2 |
1.0 |
3.80E-05 |
RAB10,
CORO1A,
RAB8B |
phagocytic vesicle membrane [CC],
phagocytic vesicle [CC] |
| CG_ff_promoter_p_PM_12_12_10 |
 |
 |
1 |
0.5 |
6.85E-05 |
DRAXIN,
MPG |
DNA-7-methylguanine glycosylase activity [MF],
DNA-7-methyladenine glycosylase activity [MF],
DNA-3-methylguanine glycosylase activity [MF],
commissural neuron differentiation in spinal cord [BP],
DNA-3-methyladenine glycosylase activity [MF] |
| CG_ff_promoter_p_PM_18_13_14 |
 |
 |
1 |
0.5 |
6.27E-05 |
SQSTM1,
SF3B3,
NBEA,
TGS1,
IQGAP1,
PAK2,
SOCS5 |
negative regulation of protein kinase activity [BP],
small nuclear ribonucleoprotein complex [CC],
protein kinase binding [MF],
receptor tyrosine kinase binding [MF] |
| CG_ff_promoter_p_PM_12_33_8 |
 |
 |
2 |
1.0 |
6.77E-05 |
DNAAF1 |
regulation of cilium beat frequency [BP] |
| CG_ff_promoter_p_PM_12_54_5 |
 |
 |
1 |
0.5 |
4.53E-05 |
ROMO1,
FTO,
RIPK1 |
positive regulation of reactive oxygen species metabolic process [BP],
oxidative DNA demethylase activity [MF],
regulation of ATP:ADP antiporter activity [BP] |
| CG_ff_promoter_p_PM_20_27_37 |
 |
 |
1 |
0.5 |
4.33E-05 |
ARHGAP35,
ARHGAP26 |
Rho GTPase activator activity [MF] |
| CG_ff_promoter_p_PM_12_58_4 |
 |
 |
1 |
0.5 |
7.37E-05 |
IFIT3,
FDX1,
NT5M,
ANXA1 |
dUMP catabolic process [BP],
mitochondrion [CC],
positive regulation of neutrophil apoptotic process [BP],
neutrophil clearance [BP] |
| CG_ff_promoter_p_PM_12_123_7 |
 |
 |
2 |
1.0 |
2.39E-04 |
CTR9 |
positive regulation of histone H3-K79 methylation [BP] |
| CG_ff_promoter_p_PM_18_37_25 |
 |
 |
3 |
1.0 |
3.86E-05 |
INTS3,
SMC3,
PSMC5,
PCF11,
RPS3,
HMG20B,
FYTTD1,
MSH2,
FANCI,
C19orf40 |
response to DNA damage stimulus [BP],
DNA repair [BP],
nucleoplasm [CC] |
| CG_ff_promoter_p_PM_12_24_13 |
 |
 |
2 |
1.0 |
3.31E-05 |
IFT88,
MIF,
IRAK2 |
dorsal/ventral pattern formation [BP],
phenylpyruvate tautomerase activity [MF],
lipopolysaccharide-mediated signaling pathway [BP],
positive regulation of prostaglandin secretion involved in immune response [BP] |
| CG_ff_promoter_p_PM_16_2_5 |
 |
 |
1 |
0.5 |
4.94E-05 |
DAK |
FAD-AMP lyase (cyclizing) activity [MF],
glycerone kinase activity [MF],
triokinase activity [MF] |
| CG_ff_promoter_p_PM_12_108_4 |
 |
 |
2 |
1.0 |
8.55E-05 |
TMX1,
PLN |
arsenate reductase (thioredoxin) activity [MF],
regulation of the force of heart contraction by cardiac conduction [BP],
regulation of relaxation of cardiac muscle [BP],
negative regulation of calcium-transporting ATPase activity [BP] |
| CG_ff_promoter_p_PM_12_56_5 |
 |
 |
1 |
0.5 |
4.96E-05 |
NOX5,
PDGFRA |
platelet-derived growth factor alpha-receptor activity [MF],
platelet-derived growth factor receptor-alpha signaling pathway [BP],
regulation of fusion of sperm to egg plasma membrane [BP] |
| CG_ff_promoter_p_PM_14_23_10 |
 |
 |
2 |
1.0 |
2.00E-05 |
AGPHD1,
TCEB3,
KDM4A,
POLR2G,
UHRF1,
SRF |
hydroxylysine kinase activity [MF],
methylated histone residue binding [MF],
core promoter proximal region sequence-specific DNA binding [MF],
contractile actin filament bundle assembly [BP],
hemi-methylated DNA-binding [MF],
positive regulation of viral transcription [BP] |
| CG_ff_promoter_p_PM_12_93_8 |
 |
 |
1 |
0.5 |
2.65E-05 |
MAPK7 |
negative regulation of heterotypic cell-cell adhesion [BP],
cellular response to laminar fluid shear stress [BP],
negative regulation of NFAT protein import into nucleus [BP] |
| CG_ff_promoter_p_PM_18_10_21 |
 |
 |
1 |
0.5 |
6.31E-05 |
NAGS,
ATG7,
ZRANB1 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process [BP],
acetyl-CoA:L-glutamate N-acetyltransferase activity [MF],
APG12 activating enzyme activity [MF] |
| CG_ff_promoter_p_PM_12_147_5 |
 |
 |
2 |
1.0 |
1.05E-04 |
RAB8A,
IRF4,
OXT,
CHRM5,
FMN2,
CLCN3,
PKP4,
MAPK6,
LONP2 |
positive regulation of hindgut contraction [BP],
meiotic chromosome movement towards spindle pole [BP],
protein binding [MF],
positive regulation of interleukin-13 biosynthetic process [BP],
oxytocin receptor binding [MF],
regulation of phosphatidylinositol dephosphorylation [BP] |
| CG_ff_promoter_p_PM_12_172_9 |
 |
 |
2 |
1.0 |
3.02E-04 |
DPPA3,
ALDH3A2 |
medium-chain-aldehyde dehydrogenase activity [MF],
long-chain-alcohol oxidase activity [MF],
long-chain-aldehyde dehydrogenase activity [MF],
negative regulation of DNA demethylation [BP],
protection of DNA demethylation of female pronucleus [BP] |
| CG_ff_promoter_p_PM_12_112_7 |
 |
 |
1 |
0.5 |
1.05E-05 |
XRCC5,
ST3GAL4,
SMARCA4 |
DNA-dependent ATPase activity [MF],
Ku70:Ku80 complex [CC],
monosialoganglioside sialyltransferase activity [MF] |
| CG_ff_promoter_p_PM_20_20_49 |
 |
 |
2 |
1.0 |
3.21E-05 |
MAP4K4,
CRELD2,
PSMF1,
CDK12,
DENR,
ARHGEF1,
ESPL1,
PCBP2,
SIN3B,
ASIP,
FBXO45,
DLAT,
VPS4A,
RAB33A,
NPM1,
RCC1,
TAF3,
FAM162A,
GTF2F2,
TAB1,
ELK3,
LDLRAP1,
CTCF,
BPTF |
regulation of molecular function, epigenetic [BP],
protein binding [MF] |
| CG_ff_promoter_p_PM_12_66_4 |
 |
 |
1 |
0.5 |
1.94E-04 |
POR,
MIF,
CCL2 |
helper T cell extravasation [BP],
lipopolysaccharide-mediated signaling pathway [BP],
phenylpyruvate tautomerase activity [MF],
negative regulation of natural killer cell chemotaxis [BP],
iron-cytochrome-c reductase activity [MF],
positive regulation of prostaglandin secretion involved in immune response [BP],
nitric oxide catabolic process [BP],
response to vitamin B3 [BP],
nitrate catabolic process [BP] |
| CG_ff_promoter_p_PM_20_12_54 |
 |
 |
2 |
1.0 |
3.81E-05 |
GDPD2,
IST1,
GDPD1,
RNF8,
CDC42,
USP8 |
midbody [CC],
cell cycle cytokinesis [BP],
glycerophosphodiester phosphodiesterase activity [MF] |
| CG_ff_promoter_p_PM_12_192_8 |
 |
 |
1 |
0.5 |
2.02E-04 |
CCDC40 |
epithelial cilium movement involved in determination of left/right asymmetry [BP],
flagellar cell motility [BP] |
| CG_ff_promoter_p_PM_18_19_30 |
 |
 |
2 |
1.0 |
9.04E-05 |
DMAP1,
SP1 |
RNA polymerase II repressing transcription factor binding [MF] |
| CG_ff_promoter_p_PM_12_74_5 |
 |
 |
2 |
1.0 |
1.09E-04 |
ARR3 |
opsin binding [MF] |
| CG_ff_promoter_p_PM_12_136_7 |
 |
 |
2 |
1.0 |
3.80E-05 |
TNFAIP3,
NDUFAF5,
MARCH7,
NDUFS5,
RNF7,
SPHK1 |
protein ubiquitination [BP],
negative regulation of CD40 signaling pathway [BP],
negative regulation of toll-like receptor 5 signaling pathway [BP],
regulation of interleukin-1 beta production [BP],
negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [BP],
negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [BP],
sphingoid catabolic process [BP],
tolerance induction to lipopolysaccharide [BP],
mitochondrial respiratory chain complex I assembly [BP] |
| CG_ff_promoter_p_PM_16_44_15 |
 |
 |
1 |
0.5 |
5.10E-05 |
PNLIPRP2,
CHAF1B,
UGCG |
DNA replication-dependent nucleosome assembly [BP],
galactolipase activity [MF],
glucosylceramide biosynthetic process [BP],
ceramide glucosyltransferase activity [MF],
CAF-1 complex [CC],
galactolipid catabolic process [BP] |
| CG_ff_promoter_p_PM_20_26_15 |
 |
 |
1 |
0.5 |
6.28E-05 |
WDR16,
GADD45G,
TAB1 |
intracellular membrane-bounded organelle [CC],
activation of MAPKKK activity [BP] |
| CG_ff_promoter_p_PM_14_32_7 |
 |
 |
1 |
0.5 |
6.84E-05 |
ACADM |
response to starvation [BP] |
| CG_ff_promoter_p_PM_18_6_22 |
 |
 |
1 |
0.5 |
3.84E-05 |
TRAF4,
WBP1,
MS4A2,
LAX1 |
WW domain binding [MF],
SH2 domain binding [MF] |
| CG_ff_promoter_p_PM_14_68_5 |
 |
 |
1 |
0.5 |
4.46E-05 |
ERCC5,
SCARA3 |
UV protection [BP] |
| CG_ff_promoter_p_PM_12_20_7 |
 |
 |
1 |
0.5 |
1.07E-04 |
MIXL1 |
positive regulation of mesoderm development [BP] |
| CG_ff_promoter_p_PM_12_130_9 |
 |
 |
1 |
0.5 |
1.73E-04 |
GLRX3 |
negative regulation of cardiac muscle hypertrophy [BP] |
| CG_ff_promoter_p_PM_14_38_10 |
 |
 |
3 |
1.0 |
3.37E-05 |
LAMTOR4 |
protein localization to lysosome [BP] |
| CG_ff_promoter_p_PM_12_82_11 |
 |
 |
2 |
1.0 |
6.27E-05 |
ADM |
adrenomedullin receptor binding [MF] |
| CG_ff_promoter_p_PM_14_43_18 |
 |
 |
2 |
0.5 |
4.33E-05 |
CPSF4,
PTPMT1 |
phosphatidylglycerophosphatase activity [MF],
modification by virus of host mRNA processing [BP] |
| CG_ff_promoter_p_PM_12_52_8 |
 |
 |
2 |
1.0 |
2.28E-05 |
CTF1,
PALM |
dendritic spine membrane [CC],
D3 dopamine receptor binding [MF],
negative regulation of dopamine receptor signaling pathway [BP],
leukemia inhibitory factor receptor binding [MF] |
| CG_ff_promoter_p_PM_12_35_4 |
 |
 |
1 |
0.5 |
3.44E-04 |
MPST |
3-mercaptopyruvate sulfurtransferase activity [MF] |
| CG_ff_promoter_p_PM_12_109_5 |
 |
 |
2 |
1.0 |
2.37E-04 |
DBI,
HMOX2,
RRP1B |
heme oxygenase (decyclizing) activity [MF],
heme oxidation [BP],
benzodiazepine receptor binding [MF],
preribosome, small subunit precursor [CC] |
| CG_ff_promoter_p_PM_14_6_8 |
 |
 |
1 |
0.5 |
9.74E-05 |
SRP54,
CD2,
GNAT1 |
positive regulation of myeloid dendritic cell activation [BP],
SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [BP],
positive regulation of cyclic-nucleotide phosphodiesterase activity [BP],
SRP-dependent cotranslational protein targeting to membrane, translocation [BP],
GDP binding [MF],
acyl binding [MF] |
| CG_ff_promoter_p_PM_18_15_22 |
 |
 |
1 |
0.5 |
7.92E-05 |
DAG1,
IMPA2 |
inositol monophosphate 1-phosphatase activity [MF],
inositol monophosphate 4-phosphatase activity [MF],
inositol monophosphate 3-phosphatase activity [MF],
nerve maturation [BP] |
| CG_ff_promoter_p_PM_12_46_5 |
 |
 |
2 |
1.0 |
2.48E-04 |
CEP72,
ZAP70 |
T cell aggregation [BP],
beta selection [BP],
gamma-tubulin complex localization [BP] |
| CG_ff_promoter_p_PM_12_138_9 |
 |
 |
2 |
1.0 |
1.89E-05 |
BNIP1,
BEST1 |
transepithelial chloride transport [BP],
endoplasmic reticulum membrane fusion [BP] |
| CG_ff_promoter_p_PM_14_22_8 |
 |
 |
1 |
0.5 |
3.25E-05 |
PNLIPRP2,
UGCG,
NUDT7,
AANAT |
acetyl-CoA catabolic process [BP],
galactolipase activity [MF],
ceramide glucosyltransferase activity [MF],
aralkylamine N-acetyltransferase activity [MF] |
| CG_ff_promoter_p_PM_12_157_9 |
 |
 |
2 |
1.0 |
1.56E-05 |
SPHK2,
UBC,
PCYOX1 |
prenylcysteine metabolic process [BP],
chloride-transporting ATPase activity [MF],
D-erythro-sphingosine kinase activity [MF],
prenylcysteine catabolic process [BP],
hypothalamus gonadotrophin-releasing hormone neuron development [BP],
ubiquitin homeostasis [BP],
sphinganine kinase activity [MF],
prenylated protein catabolic process [BP],
prenylcysteine oxidase activity [MF],
sphinganine-1-phosphate biosynthetic process [BP] |
| CG_ff_promoter_p_PM_14_58_3 |
 |
 |
2 |
1.0 |
8.28E-06 |
NCR3LG1 |
viral capsid [CC] |
| CG_ff_promoter_p_PM_14_4_22 |
 |
 |
2 |
1.0 |
7.19E-05 |
CLTA,
RIN3,
NECAP1 |
clathrin vesicle coat [CC],
endocytosis [BP],
clathrin coat [CC] |
| CG_ff_promoter_p_PM_20_11_72 |
 |
 |
2 |
1.0 |
6.09E-05 |
KNTC1,
NUP85,
POLR3F,
POLR3D,
GTF3C5,
MIS12,
RPS27 |
mitotic prometaphase [BP],
DNA-directed RNA polymerase III complex [CC],
transcription from RNA polymerase III promoter [BP] |
| CG_ff_promoter_p_PM_14_49_11 |
 |
 |
2 |
1.0 |
1.21E-04 |
BIRC5,
TPX2,
MAP2K1,
RAB7A |
Ras GTPase binding [MF],
mitosis [BP],
M phase of mitotic cell cycle [BP],
early endosome to late endosome transport [BP] |
| CG_ff_promoter_p_PM_16_43_23 |
 |
 |
2 |
1.0 |
4.68E-05 |
AQP8,
AANAT |
cellular response to cAMP [BP] |
| CG_ff_promoter_p_PM_14_35_24 |
 |
 |
2 |
1.0 |
5.13E-05 |
CNP,
MLL5,
PML |
negative regulation of translation in response to oxidative stress [BP],
extrinsic to endoplasmic reticulum membrane [CC],
2',3'-cyclic-nucleotide 3'-phosphodiesterase activity [MF],
retinoic acid receptor signaling pathway [BP] |
| CG_ff_promoter_p_PM_12_126_7 |
 |
 |
1 |
0.5 |
2.82E-05 |
SCN1B |
membrane depolarization involved in regulation of Purkinje myocyte cell action potential [BP],
voltage-gated sodium channel activity involved in regulation of Purkinje myocyte action potential [MF],
corticospinal neuron axon guidance [BP] |
| CG_ff_promoter_p_PM_14_28_11 |
 |
 |
3 |
1.0 |
7.35E-05 |
MTHFD1,
MSH2,
PLN,
MDM2,
SLC1A3,
KDM1A |
methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity [MF],
cellular response to vitamin B1 [BP],
negative regulation of DNA damage response, signal transduction by p53 class mediator [BP],
enzyme binding [MF],
cellular response to UV-C [BP],
regulation of relaxation of cardiac muscle [BP],
response to antibiotic [BP],
response to light stimulus [BP],
negative regulation of reciprocal meiotic recombination [BP],
high-affinity glutamate transmembrane transporter activity [MF],
negative regulation of calcium-transporting ATPase activity [BP],
regulation of the force of heart contraction by cardiac conduction [BP],
p53 binding [MF],
regulation of primitive erythrocyte differentiation [BP] |
| CG_ff_promoter_p_PM_14_75_17 |
 |
 |
1 |
0.5 |
2.38E-05 |
DYNLL2,
AGPAT6 |
synaptic target recognition [BP],
glandular epithelial cell maturation [BP] |
| CG_ff_promoter_p_PM_18_21_25 |
 |
 |
3 |
1.0 |
4.84E-05 |
ACOT4,
MAP2K6,
IRAK3,
RPS6KA1 |
MyD88-dependent toll-like receptor signaling pathway [BP],
dicarboxylic acid catabolic process [BP] |
| CG_ff_promoter_p_PM_12_151_6 |
 |
 |
1 |
0.5 |
4.03E-04 |
AIMP1 |
aminoacyl-tRNA synthetase multienzyme complex [CC] |
| CG_ff_promoter_p_PM_20_4_33 |
 |
 |
2 |
1.0 |
3.52E-05 |
LRRC17,
CARTPT |
negative regulation of osteoclast differentiation [BP] |
| CG_ff_promoter_p_PM_12_87_3 |
 |
 |
2 |
1.0 |
5.01E-05 |
LRTOMT,
CAV1,
NUDT9 |
catechol O-methyltransferase activity [MF],
negative regulation of tyrosine phosphorylation of Stat5 protein [BP],
ADP catabolic process [BP],
cellular response to starvation [BP],
IDP catabolic process [BP],
nitric oxide homeostasis [BP],
adenosine-diphosphatase activity [MF],
ADP-sugar diphosphatase activity [MF] |
| CG_ff_promoter_p_PM_12_164_6 |
 |
 |
1 |
0.5 |
2.03E-04 |
ESRRB |
trophectodermal cell proliferation [BP] |
| CG_ff_promoter_p_PM_14_11_7 |
 |
 |
1 |
0.5 |
2.72E-05 |
CORO1A,
LGALS8 |
negative regulation of actin nucleation [BP],
uropod organization [BP],
plasma cell differentiation [BP] |
| CG_ff_promoter_p_PM_12_124_4 |
 |
 |
1 |
0.5 |
1.10E-04 |
NUDT7,
SIRT5 |
acetyl-CoA catabolic process [BP],
peptidyl-lysine demalonylation [BP],
peptidyl-lysine desuccinylation [BP] |
| CG_ff_promoter_p_PM_20_24_46 |
 |
 |
2 |
1.0 |
5.71E-05 |
RIPK2,
MIF,
MDM2 |
positive regulation of immature T cell proliferation [BP],
negative regulation of cell cycle arrest [BP],
negative regulation of DNA damage response, signal transduction by p53 class mediator [BP] |
| CG_ff_promoter_p_PM_12_162_8 |
 |
 |
1 |
0.5 |
2.88E-04 |
D2HGDH,
ARG2 |
arginase activity [MF],
(R)-2-hydroxyglutarate dehydrogenase activity [MF] |
| CG_ff_promoter_p_PM_12_117_7 |
 |
 |
1 |
0.5 |
5.15E-06 |
PROX1,
CDT1 |
optic placode formation involved in camera-type eye formation [BP],
negative regulation of bile acid biosynthetic process [BP],
S phase of mitotic cell cycle [BP],
regulation of S phase of mitotic cell cycle [BP],
positive regulation of G1/S transition checkpoint [BP],
regulation of transcription involved in lymphatic endothelial cell fate commitment [BP],
positive regulation of forebrain neuron differentiation [BP],
DBD domain binding [MF],
hepatocyte cell migration [BP],
aorta smooth muscle tissue morphogenesis [BP] |
| CG_ff_promoter_p_PM_12_152_13 |
 |
 |
2 |
1.0 |
2.52E-04 |
FMN2 |
meiotic chromosome movement towards spindle pole [BP] |
| CG_ff_promoter_p_PM_14_17_7 |
 |
 |
1 |
0.5 |
7.62E-05 |
PTPN4,
LMNA |
cytoskeleton [CC],
sterol regulatory element binding protein import into nucleus [BP],
establishment or maintenance of microtubule cytoskeleton polarity [BP] |
| CG_ff_promoter_p_PM_12_184_10 |
 |
 |
1 |
0.5 |
2.36E-04 |
ADCY7,
AKAP5 |
positive regulation of cAMP biosynthetic process [BP] |
| CG_ff_promoter_p_PM_12_122_8 |
 |
 |
1 |
0.5 |
2.58E-05 |
SYNPO,
ADCYAP1R1 |
tight junction [CC] |
| CG_ff_promoter_p_PM_20_23_76 |
 |
 |
1 |
0.5 |
3.63E-05 |
ZNF473,
USPL1,
SENP2,
PRPF31 |
SUMO-specific protease activity [MF],
Cajal body [CC],
protein desumoylation [BP] |
| CG_ff_promoter_p_PM_14_34_7 |
 |
 |
2 |
1.0 |
3.08E-05 |
SLC5A3,
ADIPOQ,
SHROOM2 |
response to linoleic acid [BP],
negative regulation of eukaryotic cell surface binding [BP],
myo-inositol:sodium symporter activity [MF],
negative regulation of metanephric mesenchymal cell migration [BP],
eye pigment granule organization [BP],
positive regulation of renal albumin absorption [BP],
detection of oxidative stress [BP],
positive regulation of metanephric glomerular visceral epithelial cell development [BP],
negative regulation of platelet-derived growth factor receptor-alpha signaling pathway [BP] |
| CG_ff_promoter_p_PM_12_98_5 |
 |
 |
1 |
0.5 |
2.18E-04 |
CAD,
LGALS1 |
dihydroorotase activity [MF],
carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [MF],
aspartate carbamoyltransferase activity [MF],
aspartate binding [MF],
positive regulation of erythrocyte aggregation [BP] |
| CG_ff_promoter_p_PM_20_13_35 |
 |
 |
2 |
1.0 |
5.77E-05 |
TRIOBP |
myosin II binding [MF] |
| CG_ff_promoter_p_PM_16_28_25 |
 |
 |
2 |
1.0 |
1.09E-04 |
CHAF1A,
EEF2K |
CAF-1 complex [CC],
elongation factor-2 kinase activity [MF],
DNA replication-dependent nucleosome assembly [BP] |
| CG_ff_promoter_p_PM_16_10_15 |
 |
 |
3 |
1.0 |
3.12E-05 |
PHC1,
RREB1,
SLC5A3 |
nuclear body [CC],
myo-inositol:sodium symporter activity [MF] |
| CG_ff_promoter_p_PM_12_17_7 |
 |
 |
2 |
1.0 |
6.22E-05 |
MTAP,
PDGFRL,
PIGG |
CP2 mannose-ethanolamine phosphotransferase activity [MF],
S-methyl-5-thioadenosine phosphorylase activity [MF],
platelet-derived growth factor beta-receptor activity [MF] |
| CG_ff_promoter_p_PM_14_56_11 |
 |
 |
2 |
1.0 |
8.67E-05 |
SEPT7 |
regulation of embryonic cell shape [BP] |
| CG_ff_promoter_p_PM_12_120_5 |
 |
 |
1 |
0.5 |
2.33E-05 |
MIOX,
FTL,
PPOX,
DNM1L |
oxygen-dependent protoporphyrinogen oxidase activity [MF],
membrane fission involved in mitochondrial fission [BP],
ferric iron binding [MF],
dynamin polymerization involved in mitochondrial fission [BP],
inositol oxygenase activity [MF],
inositol catabolic process [BP] |
| CG_ff_promoter_p_PM_12_144_4 |
 |
 |
1 |
0.5 |
4.01E-05 |
SNX9 |
lipid tube assembly [BP] |
| CG_ff_promoter_p_PM_18_34_19 |
 |
 |
2 |
1.0 |
3.32E-05 |
PIGG |
phosphotransferase activity, for other substituted phosphate groups [MF] |
| CG_ff_promoter_p_PM_12_15_9 |
 |
 |
1 |
0.5 |
5.79E-05 |
FAM20C |
odontoblast differentiation [BP],
dentinogenesis [BP],
osteoclast maturation [BP] |
| CG_ff_promoter_p_PM_12_43_8 |
 |
 |
1 |
0.5 |
1.78E-04 |
SMYD2,
HSP90AB1 |
dATP binding [MF],
UTP binding [MF],
CTP binding [MF],
histone methyltransferase activity (H3-K36 specific) [MF],
sulfonylurea receptor binding [MF] |
| CG_ff_promoter_p_PM_20_19_58 |
 |
 |
2 |
1.0 |
5.82E-05 |
MAP1S,
ACTN4,
PLS1 |
actin filament binding [MF] |
| CG_ff_promoter_p_PM_12_121_6 |
 |
 |
1 |
0.5 |
2.71E-04 |
PRMT1,
LRSAM1,
VAPA,
OGG1 |
8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [MF],
snoRNP binding [MF],
[cytochrome c]-arginine N-methyltransferase activity [MF],
ubiquitin-dependent endocytosis [BP],
oxidized purine nucleobase lesion DNA N-glycosylase activity [MF],
cellular membrane fusion [BP] |
| CG_ff_promoter_p_PM_12_173_5 |
 |
 |
1 |
0.5 |
7.74E-05 |
P2RY6,
SUPT5H |
DSIF complex [CC],
UDP-activated nucleotide receptor activity [MF] |
| CG_ff_promoter_p_PM_16_13_27 |
 |
 |
1 |
0.5 |
2.99E-05 |
RPL38 |
translation [BP] |
| CG_ff_promoter_p_PM_12_97_8 |
 |
 |
2 |
1.0 |
1.39E-05 |
TIMM10B,
MFN2 |
mitochondrial membrane organization [BP],
protein targeting to mitochondrion [BP] |
| CG_ff_promoter_p_PM_12_100_6 |
 |
 |
2 |
1.0 |
8.51E-05 |
D2HGDH |
(R)-2-hydroxyglutarate dehydrogenase activity [MF] |
| CG_ff_promoter_p_PM_12_159_4 |
 |
 |
1 |
0.5 |
1.04E-04 |
ESRRB,
FAH |
trophectodermal cell proliferation [BP],
fumarylacetoacetase activity [MF] |
| CG_ff_promoter_p_PM_12_143_4 |
 |
 |
2 |
1.0 |
7.78E-05 |
CBR3 |
phylloquinone catabolic process [BP] |
| CG_ff_promoter_p_PM_16_34_18 |
 |
 |
2 |
1.0 |
4.11E-05 |
TCTN1 |
central nervous system interneuron axonogenesis [BP] |
| CG_ff_promoter_p_PM_14_19_9 |
 |
 |
1 |
0.5 |
3.30E-05 |
TGFBR2 |
positive regulation of tolerance induction to self antigen [BP],
bronchus morphogenesis [BP] |
| CG_ff_promoter_p_PM_12_83_9 |
 |
 |
2 |
1.0 |
5.80E-05 |
C7orf10,
MRPS17,
C14orf159,
MRPS35,
IVD |
isovaleryl-CoA dehydrogenase activity [MF],
mitochondrial small ribosomal subunit [CC],
mitochondrial matrix [CC],
mitochondrion [CC] |
| CG_ff_promoter_p_PM_12_160_4 |
 |
 |
2 |
1.0 |
3.73E-05 |
CRHBP |
negative regulation of corticotropin secretion [BP],
negative regulation of corticotropin-releasing hormone receptor activity [BP] |
| CG_ff_promoter_p_PM_12_49_8 |
 |
 |
1 |
0.5 |
2.66E-05 |
PLEK,
PDE1B |
negative regulation of inositol phosphate biosynthetic process [BP],
phospholipase C-inhibiting G-protein coupled receptor signaling pathway [BP],
cellular response to granulocyte macrophage colony-stimulating factor stimulus [BP],
positive regulation of inositol-polyphosphate 5-phosphatase activity [BP],
protein secretion by platelet [BP],
regulation of cell diameter [BP],
calmodulin-dependent cyclic-nucleotide phosphodiesterase activity [MF],
calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity [MF] |
| CG_ff_promoter_p_PM_14_29_10 |
 |
 |
2 |
1.0 |
9.70E-05 |
NMRK2 |
ribosylnicotinamide kinase activity [MF] |
| CG_ff_promoter_p_PM_12_167_6 |
 |
 |
1 |
0.5 |
2.12E-05 |
TERF2IP,
IRF4,
MALSU1 |
positive regulation of interleukin-13 biosynthetic process [BP],
negative regulation of mitochondrial translation [BP],
negative regulation of DNA recombination at telomere [BP],
positive regulation of interleukin-10 biosynthetic process [BP],
nuclear nucleosome [CC] |
| CG_ff_promoter_p_PM_16_15_19 |
 |
 |
2 |
1.0 |
1.89E-05 |
NOP58,
PRKCB |
snRNP protein import into nucleus [BP],
histone H3-T6 phosphorylation [BP] |
| CG_ff_promoter_p_PM_12_182_10 |
 |
 |
2 |
1.0 |
1.38E-04 |
FUT8 |
N-glycan fucosylation [BP],
protein glycosylation in Golgi [BP],
glycoprotein 6-alpha-L-fucosyltransferase activity [MF] |
| CG_ff_promoter_p_PM_12_186_9 |
 |
 |
2 |
1.0 |
2.35E-04 |
GPX4,
DOLPP1 |
dolichyldiphosphatase activity [MF],
phospholipid-hydroperoxide glutathione peroxidase activity [MF] |
| CG_ff_promoter_p_PM_12_36_4 |
 |
 |
1 |
0.5 |
1.29E-04 |
DUS2L,
AIP,
DLD,
NFKB1 |
negative regulation of interleukin-12 biosynthetic process [BP],
negative regulation of cyclic-nucleotide phosphodiesterase activity [BP],
flavin adenine dinucleotide binding [MF],
GAF domain binding [MF],
dihydrolipoyl dehydrogenase activity [MF] |
| CG_ff_promoter_p_PM_12_171_14 |
 |
 |
2 |
1.0 |
9.87E-06 |
TMPRSS11E,
NAALADL2 |
serine-type peptidase activity [MF],
peptidase activity [MF] |
| CG_ff_promoter_p_PM_14_13_5 |
 |
 |
1 |
0.5 |
9.01E-05 |
AGO1 |
negative regulation of translation involved in gene silencing by miRNA [BP],
micro-ribonucleoprotein complex [CC] |
| CG_ff_promoter_p_PM_12_165_5 |
 |
 |
1 |
0.5 |
2.53E-04 |
ZNF808,
ZNF543,
ZNF460,
ATF1,
PEX14,
ZNF304 |
transcription, DNA-dependent [BP],
peroxisome transport along microtubule [BP],
regulation of transcription, DNA-dependent [BP],
protein import into peroxisome matrix, substrate release [BP] |
| CG_ff_promoter_p_PM_14_54_11 |
 |
 |
1 |
0.5 |
4.44E-05 |
PTK2B,
MGAT2,
MAP2K3 |
protein tyrosine kinase activity [MF],
alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [MF],
3-phosphoinositide-dependent protein kinase binding [MF],
protein kinase binding [MF],
marginal zone B cell differentiation [BP],
positive regulation of B cell chemotaxis [BP],
regulation of cGMP-mediated signaling [BP] |
| CG_ff_promoter_p_PM_12_149_5 |
 |
 |
1 |
0.5 |
2.79E-04 |
ARL2,
PARD6A,
SERPINF2,
COL5A1 |
collagen fibril organization [BP],
tight junction assembly [BP],
collagen biosynthetic process [BP] |
| CG_ff_promoter_p_PM_16_16_9 |
 |
 |
1 |
0.5 |
5.59E-05 |
IFT74,
HGSNAT,
ITPR3,
DNAAF1,
ALPL,
PSEN1 |
heparan-alpha-glucosaminide N-acetyltransferase activity [MF],
Cajal-Retzius cell differentiation [BP],
cementum mineralization [BP],
regulation of cilium beat frequency [BP],
inositol hexakisphosphate binding [MF],
motile cilium [CC],
nuclear outer membrane [CC] |
| CG_ff_promoter_p_PM_12_177_5 |
 |
 |
2 |
1.0 |
1.01E-04 |
HEXB,
HSD11B1,
SEPT7 |
regulation of cell shape [BP],
male courtship behavior [BP],
11-beta-hydroxysteroid dehydrogenase (NADP+) activity [MF],
11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity [MF],
regulation of embryonic cell shape [BP] |
| CG_ff_promoter_p_PM_12_158_4 |
 |
 |
2 |
1.0 |
4.04E-04 |
NADSYN1 |
NAD+ synthase (glutamine-hydrolyzing) activity [MF] |
| CG_ff_promoter_p_PM_12_181_9 |
 |
 |
1 |
0.5 |
3.87E-05 |
KCNK3,
PEX14 |
open rectifier potassium channel activity [MF],
negative regulation of protein homotetramerization [BP],
peroxisome transport along microtubule [BP],
protein import into peroxisome matrix, substrate release [BP] |
| CG_ff_promoter_p_PM_16_14_45 |
 |
 |
2 |
1.0 |
4.18E-05 |
LSM14B,
USP9X,
SMAD3,
RPS7,
BMPR1B,
LARP7 |
co-SMAD binding [MF],
ribonucleoprotein complex [CC],
BMP signaling pathway [BP] |
| CG_ff_promoter_p_PM_12_102_3 |
 |
 |
2 |
1.0 |
1.49E-04 |
AGPS,
ZRANB1,
SDHA |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process [BP],
alkylglycerone-phosphate synthase activity [MF],
succinate dehydrogenase (ubiquinone) activity [MF],
flavin adenine dinucleotide binding [MF] |
| CG_ff_promoter_p_PM_12_193_9 |
 |
 |
1 |
0.5 |
7.12E-06 |
EPCAM,
WNT6,
NSD1 |
ureteric bud development [BP],
histone methyltransferase activity (H4-K20 specific) [MF],
positive regulation of tooth mineralization [BP],
histone methyltransferase activity (H3-K36 specific) [MF] |
| CG_ff_promoter_p_PM_12_156_5 |
 |
 |
1 |
0.5 |
1.10E-04 |
SYNGR3,
KCNIP1,
ASNSD1 |
asparagine biosynthetic process [BP],
protein N-terminus binding [MF] |
| CG_ff_promoter_p_PM_12_2_4 |
 |
 |
1 |
0.5 |
3.06E-05 |
UPB1 |
beta-alanine biosynthetic process [BP],
beta-ureidopropionase activity [MF] |
| CG_ff_promoter_p_PM_12_88_4 |
 |
 |
1 |
0.5 |
2.54E-04 |
KIT,
SMARCA2 |
melanocyte migration [BP],
stem cell factor receptor activity [MF],
aortic smooth muscle cell differentiation [BP],
melanocyte adhesion [BP] |
| CG_ff_promoter_p_PM_12_18_4 |
 |
 |
1 |
0.5 |
1.44E-04 |
ENOPH1,
PCED1B,
AMDHD2 |
acireductone synthase activity [MF],
N-acetylglucosamine-6-phosphate deacetylase activity [MF],
hydrolase activity [MF] |
| CG_ff_promoter_p_PM_12_95_7 |
 |
 |
2 |
1.0 |
2.03E-04 |
KHK,
STXBP2 |
ketohexokinase activity [MF],
syntaxin-3 binding [MF] |
| CG_ff_promoter_p_PM_14_51_10 |
 |
 |
1 |
0.5 |
4.36E-06 |
INPPL1,
BTD |
biotinidase activity [MF],
actin cortical patch [CC] |
| CG_ff_promoter_p_PM_16_40_17 |
 |
 |
2 |
1.0 |
2.65E-05 |
UBC |
hypothalamus gonadotrophin-releasing hormone neuron development [BP] |
| CG_ff_promoter_p_PM_18_28_19 |
 |
 |
2 |
1.0 |
4.35E-05 |
TTLL3,
HCK |
regulation of podosome assembly [BP],
axoneme assembly [BP] |
| CG_ff_promoter_p_PM_18_17_30 |
 |
 |
2 |
1.0 |
4.17E-05 |
SPTBN4,
ATP2A2,
SPTAN1 |
negative regulation of heart contraction [BP],
spectrin binding [MF],
spectrin [CC] |
| CG_ff_promoter_p_PM_12_14_9 |
 |
 |
1 |
0.5 |
2.29E-04 |
ELN |
elastic fiber [CC],
extracellular matrix constituent conferring elasticity [MF] |
| CG_ff_promoter_p_PM_12_175_6 |
 |
 |
1 |
0.5 |
1.53E-04 |
MPST |
3-mercaptopyruvate sulfurtransferase activity [MF],
cyanate catabolic process [BP] |
| CG_ff_promoter_p_PM_14_70_19 |
 |
 |
2 |
1.0 |
1.03E-04 |
SPAST,
AGPAT6 |
cytokinesis, completion of separation [BP],
glandular epithelial cell maturation [BP] |
| CG_ff_promoter_p_PM_12_38_9 |
 |
 |
2 |
1.0 |
7.94E-05 |
TNK1,
DAB2IP,
COX10 |
heme O biosynthetic process [BP],
protoheme IX farnesyltransferase activity [MF],
negative regulation of Ras protein signal transduction [BP] |
| CG_ff_promoter_p_PM_20_7_32 |
 |
 |
2 |
1.0 |
1.04E-04 |
BRE,
SMAD3,
COPG1,
DNAJB2 |
polyubiquitin binding [MF],
ubiquitin binding [MF],
organelle transport along microtubule [BP] |
| CG_ff_promoter_p_PM_14_60_27 |
 |
 |
4 |
1.0 |
1.59E-05 |
KIF15 |
plus-end kinesin complex [CC] |
| CG_ff_promoter_p_PM_12_163_8 |
 |
 |
1 |
0.5 |
1.13E-04 |
THTPA,
SART1 |
positive regulation of cytotoxic T cell differentiation [BP],
thiamin-triphosphatase activity [MF] |
| CG_ff_promoter_p_PM_20_1_26 |
 |
 |
2 |
1.0 |
5.14E-05 |
RBM17,
WAC,
STRAP,
GEMIN2 |
spliceosomal complex [CC] |
| CG_ff_promoter_p_PM_12_142_5 |
 |
 |
1 |
0.5 |
1.69E-04 |
STRA8,
KLC3 |
meiotic cell cycle DNA replication checkpoint [BP],
cardiolipin synthase activity [MF] |
| CG_ff_promoter_p_PM_12_6_8 |
 |
 |
1 |
0.5 |
2.42E-05 |
ATP2A1 |
elevation of endoplasmic reticulum calcium ion concentration [BP],
calcium ion import [BP],
relaxation of skeletal muscle [BP],
positive regulation of fast-twitch skeletal muscle fiber contraction [BP] |
| CG_ff_promoter_p_PM_12_111_5 |
 |
 |
1 |
0.5 |
5.43E-05 |
CSF3 |
granulocyte colony-stimulating factor receptor binding [MF] |
| CG_ff_promoter_p_PM_16_42_14 |
 |
 |
2 |
1.0 |
2.92E-05 |
NBEA,
TGS1,
PAK2,
SQSTM1 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [BP],
protein kinase binding [MF],
RNA trimethylguanosine synthase activity [MF],
7-methylguanosine cap hypermethylation [BP] |
| CG_ff_promoter_p_PM_12_187_7 |
 |
 |
2 |
1.0 |
2.01E-04 |
SGPL1,
SMAD1,
SOX8,
KLF11,
HES1 |
ureteric bud development [BP],
midbrain development [BP],
hindbrain development [BP],
metanephric nephron tubule morphogenesis [BP],
kidney development [BP],
transcription regulatory region DNA binding [MF],
positive regulation of gliogenesis [BP],
RNA polymerase II core promoter sequence-specific DNA binding [MF] |
| CG_ff_promoter_p_PM_14_47_5 |
 |
 |
2 |
1.0 |
3.87E-05 |
SWSAP1,
RCL1 |
Shu complex [CC],
RNA-3'-phosphate cyclase activity [MF] |
| CG_ff_promoter_p_PM_12_128_6 |
 |
 |
1 |
0.5 |
2.63E-05 |
BOK,
MYOCD,
TEF,
AMD1,
ZHX2 |
S-adenosylmethioninamine biosynthetic process [BP],
adenosylmethionine decarboxylase activity [MF],
positive regulation of cardiac vascular smooth muscle cell differentiation [BP],
protein heterodimerization activity [MF] |
| CG_ff_promoter_p_PM_12_79_5 |
 |
 |
1 |
0.5 |
9.79E-05 |
HNF1A,
ALAS1 |
heme biosynthetic process [BP],
fatty acid transport [BP] |
| CG_ff_promoter_p_PM_12_84_5 |
 |
 |
1 |
0.5 |
7.11E-05 |
PPOX |
oxygen-dependent protoporphyrinogen oxidase activity [MF] |
| CG_ff_promoter_p_PM_14_39_14 |
 |
 |
1 |
0.5 |
7.78E-05 |
ZRANB1,
ST3GAL3 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process [BP],
N-acetyllactosaminide alpha-2,3-sialyltransferase activity [MF] |
| CG_ff_promoter_p_PM_14_52_6 |
 |
 |
1 |
0.5 |
3.86E-05 |
BAG4,
RABGAP1,
TRHR,
TBC1D29,
IL18BP,
SRP54 |
negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [BP],
SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [BP],
SRP-dependent cotranslational protein targeting to membrane, translocation [BP],
Rab GTPase activator activity [MF],
interleukin-18 binding [MF],
thyrotropin-releasing hormone receptor activity [MF] |
| CG_ff_promoter_p_PM_12_8_6 |
 |
 |
2 |
0.5 |
1.14E-04 |
MED25 |
positive regulation of chromatin binding [BP],
positive regulation of mediator complex assembly [BP] |
| CG_ff_promoter_p_PM_16_3_4 |
 |
 |
1 |
0.5 |
4.72E-05 |
GALK2 |
N-acetylgalactosamine kinase activity [MF],
galactokinase activity [MF] |
| CG_ff_promoter_p_PM_12_189_5 |
 |
 |
2 |
1.0 |
7.05E-05 |
SLC39A5 |
cellular response to zinc ion starvation [BP] |
| CG_ff_promoter_p_PM_14_30_10 |
 |
 |
3 |
1.0 |
3.47E-05 |
CHP2,
FURIN,
LONP2 |
positive regulation of phosphatase activity [BP],
signal peptide processing [BP] |
| CG_ff_promoter_p_PM_12_69_9 |
 |
 |
1 |
0.5 |
2.98E-05 |
TSEN34,
LRP5,
OTX1,
C1GALT1,
LRAT,
WNT3A |
phosphatidylcholine-retinol O-acyltransferase activity [MF],
positive regulation of canonical Wnt receptor signaling pathway involved in controlling type B pancreatic cell proliferation [BP],
tRNA-type intron splice site recognition and cleavage [BP],
anterior/posterior pattern specification [BP],
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [MF],
positive regulation of mesodermal cell fate specification [BP] |
| CG_ff_promoter_p_PM_20_5_40 |
 |
 |
2 |
1.0 |
4.39E-05 |
PINLYP,
RPS3,
APOC1,
PSMA6,
LYN,
IL20RB |
phospholipase inhibitor activity [MF],
lipase inhibitor activity [MF],
regulation of inflammatory response [BP],
NF-kappaB binding [MF],
immune response-inhibiting signal transduction [BP] |
| CG_ff_promoter_p_PM_12_169_6 |
 |
 |
2 |
1.0 |
1.68E-04 |
ALDH1A3,
PMM2 |
nucleus accumbens development [BP],
phosphomannomutase activity [MF] |
| CG_ff_promoter_p_PM_12_94_12 |
 |
 |
1 |
0.5 |
8.85E-06 |
VDAC3 |
adenine transport [BP] |
| CG_ff_promoter_p_PM_12_115_11 |
 |
 |
1 |
0.5 |
2.49E-05 |
TPI1,
TAS1R3 |
sweet taste receptor activity [MF],
detection of chemical stimulus involved in sensory perception of sweet taste [BP],
glyceraldehyde-3-phosphate metabolic process [BP],
triose-phosphate isomerase activity [MF] |
| CG_ff_promoter_p_PM_12_154_9 |
 |
 |
1 |
0.5 |
1.42E-04 |
HADHB,
MARC1,
LAMTOR4 |
long-chain-3-hydroxyacyl-CoA dehydrogenase activity [MF],
mitochondrial fatty acid beta-oxidation multienzyme complex [CC],
protein localization to lysosome [BP],
nitrate metabolic process [BP],
nitrate reductase activity [MF],
long-chain-enoyl-CoA hydratase activity [MF] |
| CG_ff_promoter_p_PM_12_188_11 |
 |
 |
2 |
1.0 |
3.13E-04 |
PTS,
CD81 |
6-pyruvoyltetrahydropterin synthase activity [MF],
positive regulation of 1-phosphatidylinositol 4-kinase activity [BP] |
| CG_ff_promoter_p_PM_12_185_9 |
 |
 |
2 |
1.0 |
1.27E-04 |
PNP,
RAB7A,
FADS2,
PINK1 |
NAD biosynthesis via nicotinamide riboside salvage pathway [BP],
C3HC4-type RING finger domain binding [MF],
purine-nucleoside phosphorylase activity [MF],
inosine catabolic process [BP],
nicotinamide riboside catabolic process [BP],
epidermal growth factor catabolic process [BP],
unsaturated fatty acid biosynthetic process [BP] |
| CG_ff_promoter_p_PM_12_9_11 |
 |
 |
2 |
0.5 |
1.26E-04 |
MGAM,
HPN,
SLC50A1,
HSF1 |
pilomotor reflex [BP],
glucoside transmembrane transporter activity [MF],
basement membrane disassembly [BP],
glucoside transport [BP],
RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [MF],
glucan 1,4-alpha-glucosidase activity [MF],
starch catabolic process [BP] |
| CG_ff_promoter_p_PM_14_14_9 |
 |
 |
1 |
0.5 |
8.39E-04 |
LRSAM1 |
ubiquitin-dependent endocytosis [BP],
non-lytic virus budding [BP] |
| CG_ff_promoter_p_PM_12_183_14 |
 |
 |
2 |
1.0 |
4.02E-05 |
IL34,
LIPC |
macrophage colony-stimulating factor receptor binding [MF],
intermediate-density lipoprotein particle remodeling [BP] |
| CG_ff_promoter_p_PM_14_3_19 |
 |
 |
3 |
1.0 |
2.66E-05 |
TIMP1,
EPO |
erythrocyte maturation [BP] |
| CG_ff_promoter_p_PM_12_4_4 |
 |
 |
2 |
1.0 |
1.06E-04 |
CSGALNACT2 |
dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [BP] |
| CG_ff_promoter_p_PM_14_2_16 |
 |
 |
3 |
1.0 |
4.88E-05 |
SMARCA2 |
aortic smooth muscle cell differentiation [BP] |